We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+25.57%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$25.4B
AUM Growth
+$5.37B
Cap. Flow
+$508M
Cap. Flow %
2%
Top 10 Hldgs %
19.14%
Holding
1,320
New
149
Increased
490
Reduced
420
Closed
99

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$82.6M
2
AMZN icon
Amazon
AMZN
+$51.1M
3
EBAY icon
eBay
EBAY
+$50.4M
4
NFLX icon
Netflix
NFLX
+$45.5M
5
RTX icon
RTX Corp
RTX
+$36.9M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$190M
2
MA icon
Mastercard
MA
+$48.9M
3
RTN
Raytheon Company
RTN
+$44.4M
4
PEP icon
PepsiCo
PEP
+$43.1M
5
SPGI icon
S&P Global
SPGI
+$42M

Sector Composition

Rank Sector Weight
1 Technology 28.14%
2 Healthcare 19.28%
3 Consumer Discretionary 11.02%
4 Financials 10.21%
5 Industrials 6.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHD icon
276
Church & Dwight Co
CHD
$23.7B
$18.7M 0.07%
241,421
-55,814
-19% -$4.06M
ALB icon
277
Albemarle
ALB
$13.4B
$18.6M 0.07%
240,827
+163,374
+211% +$11.1M
ARE icon
278
Alexandria Real Estate Equities
ARE
$9.37B
$18.6M 0.07%
114,432
+24,028
+27% +$3.67M
ALNY icon
279
Alnylam Pharmaceuticals
ALNY
$38.3B
$18.5M 0.07%
124,961
+5,313
+4% +$716K
ROK icon
280
Rockwell Automation
ROK
$51.1B
$18.5M 0.07%
86,851
-3,580
-4% -$692K
KEY icon
281
KeyCorp
KEY
$23.8B
$18.5M 0.07%
1,518,848
+1,460,066
+2,484% +$17M
LULU icon
282
lululemon athletica
LULU
$13.5B
$18.5M 0.07%
59,279
+263
+0.4% +$67.3K
BEN icon
283
Franklin Resources
BEN
$16.8B
$18.4M 0.07%
879,622
+3,965
+0.5% +$74.8K
MOH icon
284
Molina Healthcare
MOH
$10.4B
$18.4M 0.07%
103,588
+98,988
+2,152% +$16.9M
RCL icon
285
Royal Caribbean
RCL
$86.8B
$18.4M 0.07%
364,931
+58,158
+19% +$2.63M
MRSH
286
Marsh
MRSH
$94.3B
$18.3M 0.07%
170,451
+5,276
+3% +$534K
CTAS icon
287
Cintas
CTAS
$86.6B
$18M 0.07%
270,720
-200,488
-43% -$11.6M
HBI
288
DELISTED
Hanesbrands
HBI
$17.9M 0.07%
1,586,400
-136,500
-8% -$1.36M
MASI
289
DELISTED
Masimo
MASI
$17.9M 0.07%
78,313
-23,450
-23% -$5.15M
CIEN icon
290
Ciena
CIEN
$46.8B
$17.8M 0.07%
328,000
+41,800
+15% +$2.08M
RARE icon
291
Ultragenyx Pharmaceutical
RARE
$2.46B
$17.8M 0.07%
227,108
-69,509
-23% -$4.6M
EQH icon
292
Equitable Holdings
EQH
$13.2B
$17.7M 0.07%
917,300
-15,900
-2% -$284K
EXC icon
293
Exelon
EXC
$48.1B
$17.6M 0.07%
678,631
+28,177
+4% +$748K
APH icon
294
Amphenol
APH
$185B
$17.6M 0.07%
732,660
-51,388
-7% -$1.15M
LVS icon
295
Las Vegas Sands
LVS
$32.2B
$17.3M 0.07%
380,392
+266,239
+233% +$12.5M
HIG icon
296
Hartford Financial Services
HIG
$39.9B
$17.3M 0.07%
449,068
+3,871
+0.9% +$148K
BF.B icon
297
Brown-Forman Class B
BF.B
$13.5B
$17.3M 0.07%
271,180
+25,090
+10% +$1.6M
CMI icon
298
Cummins
CMI
$83.6B
$17.3M 0.07%
99,602
+2,860
+3% +$457K
ZBRA icon
299
Zebra Technologies
ZBRA
$13.5B
$17.2M 0.07%
67,368
+56,031
+494% +$13.1M
INSM icon
300
Insmed
INSM
$22.4B
$17.1M 0.07%
622,670
+74,925
+14% +$1.78M

Similar funds

Axa's Q2 2020 Portfolio in Review

As of Q2 2020, Axa held 1,320 positions worth $25.4B, up 27% from $20B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Axa's Q2 2020 filing shows 149 new, 490 increased, 420 reduced and 99 closed positions. Its largest new stake was Exelixis: 820,990 shares worth $19.5M. The largest sale was Linde, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Axa's largest Q2 2020 buy was Exelixis: 820,990 shares worth $19.5M.
  • Axa added most to Microsoft in Q2 2020, an estimated $82.6M increase.
  • Axa's biggest Q2 2020 reduction was Linde, cutting an estimated $190M.
  • Axa fully exited Raytheon Company in Q2 2020, selling an estimated $44.4M.
  • Axa's ten largest holdings make up 19% of its $25.4B portfolio in Q2 2020.
  • Axa opened 149 new positions and closed 99 in Q2 2020.
  • Axa's portfolio value rose 27% quarter-over-quarter to $25.4B.

Based on Axa's 13F filing for Q2 2020, filed 14 Aug 2020.